{{medical}}
{{Template:PBB/1815}}
{{DISPLAYTITLE:多巴胺受体D<sub>4</sub>}}
'''多巴胺受体D<sub>4</sub>'''是一种由{{gene|DRD4}}基因编码的[[G蛋白偶联受体|G蛋白偶联受体]]。<ref name="pmid1840645">{{cite journal | author = Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O | title = Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | journal = Nature | volume = 350 | issue = 6319 | pages = 610–4 | pmid = 1840645 | doi = 10.1038/350610a0 | url =  |date=April 1991}}</ref>

和其他[[多巴胺受体|多巴胺受体]]亚型一样, D<sub>4</sub>受体由[[神经递质|神经递质]]——[[多巴胺|多巴胺]]激活。它与[[精神分裂症|精神分裂症]],[[帕金森症|帕金森症]],[[躁郁症|躁郁症]]，上瘾行为，以及诸如[[神经性厌食症|厌食症]], [[贪食症|贪食症]]和[[暴食症|暴食症]]等[[神经性进食紊乱症|神经性进食紊乱症]]等许多神经学或心理学状况相关。 

此受体也是许多治疗[[精神分裂症|精神分裂症]]和[[帕金森症|帕金森症]]的靶标. D<sub>4</sub>受体被认为与[[多巴胺受体D2|D<sub>2</sub>-类似]]，被激活的受体抑制[[腺甙酸环化酶|腺甙酸环化酶]]，从而减少细胞内第二信息递质[[环磷腺苷|环磷腺苷]] 的浓度。<ref name="pmid15521361">{{cite journal | author = Neve KA, Seamans JK, Trantham-Davidson H | title = Dopamine receptor signaling | journal = J. Recept. Signal Transduct. Res. | volume = 24 | issue = 3 | pages = 165–205 | pmid = 15521361 | url =  | doi = 10.1081/RRS-200029981 |date=August 2004}}</ref>

==基因学==
此人体蛋白由 [[11号染色体|11号染色体]]上位于[[11p15.5|11p15.5]]的基因''DRD4''编码。

人类基因中有轻微的变化（变异/多态)：
* 在[[外显子|外显子]]3的一处48-碱基对[[VNTR|VNTR]]
* 启动子中的[[C-521T|C-521T]]
* 外显子1中碱基235至247的13-碱基对删除
* 外显子I中12碱基对重复。<ref name="pmid8268330">{{cite journal | author = Catalano M, Nobile M, Novelli E, Nöthen MM, Smeraldi E | title = Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients | journal = Biol. Psychiatry | volume = 34 | issue = 7 | pages = 459–64 | pmid = 8268330 | doi = 10.1016/0006-3223(93)90236-7 | url =   |date=October 1993}}</ref>
* [[Val194Gly|Val194Gly]]
* 120bp处的多态串联重复

此基因的变异与多种行为表型相关，包括[[自主神经系统|自主神经系统]]失常，[[注意缺陷障碍|注意缺陷障碍]]，<ref name="pmid17506925">{{cite journal | author = Thapar A, Langley K, Owen MJ, O'Donovan MC | title = Advances in genetic findings on attention deficit hyperactivity disorder | journal = Psychol Med | volume = 37 | issue = 12 | pages = 1681–92 | pmid = 17506925 | doi = 10.1017/S0033291707000773 | url =  |date=December 2007}}</ref> [[精神分裂症|精神分裂症]],<ref name="SZGeneD4">[http://www.schizophreniaforum.org/res/sczgene/geneoverview.asp?geneid=94 Gene Overview of All Published Schizophrenia-Association Studies for DRD4] {{webarchive|url=https://web.archive.org/web/20090221130224/http://schizophreniaforum.org/res/sczgene/geneoverview.asp?geneid=94 |date=2009-02-21 }} - [[SzGene|SzGene]] database at [[Schizophrenia_Research_Forum|Schizophrenia Research Forum]].</ref> 以及[[寻求新奇|寻求新奇]]的人格特征。<ref name="pmid17574217">{{cite journal | author = Munafò MR, Yalcin B, Willis-Owen SA, Flint J | title = Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data | journal = Biol. Psychiatry | volume = 63 | issue = 2 | pages = 197–206 | pmid = 17574217 | doi = 10.1016/j.biopsych.2007.04.006 | url =  |date=January 2008}}</ref>

=== 48-碱基对VNTR(可变数量串联重复) ===

[[外显子|外显子]]3中的48-碱基对可变数量串联重复（VNTR）有2至11次重复。
等位基因的频率在人群中变化很大，例如，7-重复版本在美洲很高而在亚洲则很低。<ref name="pmid15077199">{{cite journal | author = Wang E, Ding YC, Flodman P, Kidd JR, Kidd KK, Grady DL, Ryder OA, Spence MA, Swanson JM, Moyzis RK | title = The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus | journal = Am. J. Hum. Genet. | volume = 74 | issue = 5 | pages = 931–44 | pmid = 15077199 | pmc = 1181986 | doi = 10.1086/420854 | url =  |date=May 2004}}</ref> “长”版本的多态基因是重复6到10次的等位基因。7R对多巴胺分子的反应强度似乎要略弱一些。<ref name="pmid7643093">{{cite journal
 | author = Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH
 | title = Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants
 | journal = J Neurochem
 | volume = 65 | issue = 3 | pages = 1157–1165
 | pmid = 7643093
 | doi = 10.1046/j.1471-4159.1995.65031157.x
|date=September 1995}}</ref>


'长DRD4'变体, 或更具体地即7重复(7R)，松散地与形成[[ADHD|ADHD]] <ref name="pmid11431226">{{cite journal
 | author = [[Stephen_V._Faraone|Faraone SV]], Doyle AE, Mick E, Biederman J
 | title = Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder
 | journal = [[American_Journal_of_Psychiatry|American Journal of Psychiatry]]
 | volume = 158 | issue = 7 | pages = 1052–7
 | pmid = 11431226
 | doi = 10.1176/appi.ajp.158.7.1052
 | url = http://ajp.psychiatryonline.org/cgi/content/full/158/7/1052
|date=July 2001}}</ref>
以及其它的心理特征和异常的易感性相关。

48-碱基对VNTR已经成为了在跨文化环境下对其在人类行为的进化和角色方面所作出的诸多推测的主题。7R等位基因似乎在4万年前就已经被选择出来。<ref name="pmid15077199"/> 1999年，陈（音）及其同事<ref name="Chen_1999">{{cite journal | author =  Chen CS, Burton M, Greenberger E, Dmitrieva J | title =  Population migration and the variation of dopamine D4 receptor (DRD4) allele frequencies around the globe | journal =  Evolution and Human Behavior | volume = 20 | issue =  5 | pages =  309–324 | pmid = | doi = 10.1016/S1090-5138(99)00015-X | url =   |date=September 1999}}</ref> 观察到那些在过去3万年到1万年间迁移得比较远的人类群体带有7R/长等位基因的频率较高。他们也指出游牧人群带有7R等位基因的频率比定居人群高。 较近期，也有观察到拥有7R等位基因的游牧人[[阿里尔人|阿里尔人]]健康状况更好。然而，定居不久的（非游牧）带有7R等位基因的阿里尔人似乎有轻微的健康退化状况。<ref name="pmid18544160">{{cite journal | author = Eisenberg DT, Campbell B, Gray PB, Sorenson MD | title = Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya | journal = BMC Evol. Biol. | volume = 8| pages = 173 | year = 2008 | pmid = 18544160 | pmc = 2440754 | doi = 10.1186/1471-2148-8-173 | url =  }}</ref>

==寻奇性格==

尽管有关于DRD4 48碱基对VNTR与“寻奇性格”（具有爱探索和爱刺激人的一种性格特质）之间关联的早期发现，<ref name="pmid8528256">{{cite journal | author = Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH | title = Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking | journal = Nat. Genet. | volume = 12 | issue = 1 | pages = 78–80 | pmid = 8528256 | doi = 10.1038/ng0196-78 |date=January 1996}}</ref><ref name="pmid8528258">{{cite journal | author = Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH | title = Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking | journal = Nat. Genet. | volume = 12 | issue = 1 | pages = 81–4 | pmid = 8528258 | doi = 10.1038/ng0196-81 |date=January 1996}}</ref> 2008年的一项 [[元分析|元分析]]对比了36份出版了的关于“寻奇性格”和多态性的研究，没有找到有效相关性。关于11份研究的元分析确发现了基因的另一多态性——[[-521C/T|-521C/T]]显示出与“寻奇性格”的联系。<ref name>{{cite journal | author = Munafo MR, Yalcin B, Willis-Owen SA, Flint J. | title =  Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data | journal =Biol Psychiatry | volume = 63| issue = 2| pages = 197–206 | year = 2008 | doi = 10.1016/j.biopsych.2007.04.006 | pmid = 17574217}}</ref> 。究其各种情况，“寻奇”行为可能是由几个基因介导的，仅归因于DRD4本身所造成的变化并不是特别大。

==认知发展==
有一些研究指出育儿过程可能影响带有DRD4 7-重复等位基因儿童的[[认知发展|认知发展]]。<ref name="Posner">{{cite journal | author = Posner MI, Rothbart MK, Sheese BE, Voelker P | title = Control networks and neuromodulators of early development | journal = Dev Psychol | volume = 48 | issue = 3 | pages = 827–35 | pmid = 21942663 | doi = 10.1037/a0025530 |date=May 2012}}</ref> 具有母性感受、正念和自治支持的育儿过程在15个月时对儿童后来在18至20个月的[[执行性功能|执行性功能]]有益<!--不确定英文版意思--><ref name=Posner/> 经历较差育儿过程的儿童比那些有较好经历者更冲动且更追求感官刺激。<ref name=Posner/>高质量的育儿过程与儿童在四岁时较好的[[努力控制|努力控制]] 相关。<ref name=Posner/>

==配体==
[[Image:D4_ligands.png|thumbnail]]
<!--
PMID 10479303
PMID 9406594
PMID 9276014
PMID 8968364
PMID 9871530 
PMID 12362366
-->

===激动剂===
* [[WAY-100635|WAY-100635]]: 全效 [[激动剂|激动剂]], 带有5-HT<sub>1A</sub>拮抗组分<ref name="pmid16915381">{{cite journal | author = Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE | title = WAY-100635 is a potent dopamine D4 receptor agonist | journal = Psychopharmacology (Berl.) | volume = 188 | issue = 2 | pages = 244–51 | year = 2006 | pmid = 16915381 | doi = 10.1007/s00213-006-0490-4 }}</ref>
* [[A-412,997|A-412,997]]: 完全激动剂, 对超过79种不同的受体和离子通道选择性>100倍。<ref name="pmid16153699">{{cite journal | author = Moreland RB, Patel M, Hsieh GC, Wetter JM, Marsh K, Brioni JD | title = A-412997 is a selective dopamine D<sub>4</sub> receptor agonist in rats | journal = Pharmacol. Biochem. Behav. | volume = 82 | issue = 1 | pages = 140–7 | year = 2005 | pmid = 16153699 | doi = 10.1016/j.pbb.2005.08.001 }}</ref>
* [[ABT-724|ABT-724]] - 开发用于治疗勃起功能障碍<ref name="pmid15239663">{{cite journal |author=Cowart M, Latshaw SP, Bhatia P, Daanen JF, Rohde J, Nelson SL, Patel M, Kolasa T, Nakane M, Uchic ME, Miller LN, Terranova MA, Chang R, Donnelly-Roberts DL, Namovic MT, Hollingsworth PR, Martino BR, Lynch JJ, Sullivan JP, Hsieh GC, Moreland RB, Brioni JD, Stewart AO |title=Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction |journal=Journal of Medicinal Chemistry |volume=47 |issue=15 |pages=3853–64 |pmid=15239663 |doi=10.1021/jm030505a |url=|date=July 2004}}</ref>
* [[ABT-670|ABT-670]] - 比ABT-724口服生物利用率高<ref>{{cite journal |author=Patel MV, Kolasa T, Mortell K, ''et al.'' |title=Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction |journal=J. Med. Chem. |volume=49 |issue=25 |pages=7450–65 |pmid=17149874 |doi=10.1021/jm060662k|date=December 2006}}</ref>
* FAUC 316: 部分激动剂, 对其他多巴胺受体子类型选择性>8600-fold倍<ref name="pmid11087581">{{cite journal | author = Hübner H, Kraxner J, Gmeiner P | title = Cyanoindole derivatives as highly selective dopamine D<sub>4</sub> receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments | journal = J. Med. Chem. | volume = 43 | issue = 23 | pages = 4563–9 | year = 2000 | pmid = 11087581 | doi = 10.1021/jm0009989 }}</ref>
* FAUC 299: 部分激动剂<ref name="pmid11087581"/>
* (''E'')-1-芳基-3-(4-吡啶哌啶-1-基）丙酮肟<ref>{{cite journal |author=Kolasa T, Matulenko MA, Hakeem AA, ''et al.'' |title=1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction |journal=J. Med. Chem. |volume=49 |issue=17 |pages=5093–109 |pmid=16913699 |doi=10.1021/jm060279f|date=August 2006}}</ref>
* PIP3EA: 部分激动剂<ref>{{cite journal |author=Enguehard-Gueiffier C, Hübner H, El Hakmaoui A, ''et al.'' |title=2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist |journal=J. Med. Chem. |volume=49 |issue=13 |pages=3938–47 |pmid=16789750 |doi=10.1021/jm060166w|date=June 2006}}</ref>
* [[Flibanserin|Flibanserin]] - 部分激动剂
* [[PD-168,077|PD-168,077]] - D<sub>4</sub>选择性但也绑定到α1A, α2C 和 5HT<sub>1A</sub>
* [[CP-226,269|CP-226,269]] - D<sub>4</sub>选择性但也绑定到D<sub>2</sub>, D<sub>3</sub>, α2A, α2C 和 5HT<sub>1A</sub>
* [[Ro10-5824|Ro10-5824]] - 部分激动剂

===受体拮抗剂===
* A-381393: 强效，亚型选择性[[受体拮抗剂|拮抗剂]] (>2700倍)<ref>{{cite journal |author=Nakane M, Cowart MD, Hsieh GC, ''et al.'' |title=2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist |journal=Neuropharmacology |volume=49 |issue=1 |pages=112–21 |pmid=15992586 |doi=10.1016/j.neuropharm.2005.02.004|date=July 2005}}</ref>
* FAUC 213<ref name = "pmid18307287"/>
* [[L-745,870|L-745,870]]<ref>{{cite journal |author=Kulagowski JJ, Broughton HB, Curtis NR, ''et al.'' |title=3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor |journal=J. Med. Chem. |volume=39 |issue=10 |pages=1941–2 |pmid=8642550 |doi=10.1021/jm9600712|date=May 1996}}</ref><ref>{{cite journal |author=Patel S, Freedman S, Chapman KL, ''et al.'' |title=Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor |journal=J. Pharmacol. Exp. Ther. |volume=283 |issue=2 |pages=636–47 |date=1 November 1997|pmid=9353380 |url=http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9353380 }}</ref>
* L-750,667<ref>{{cite journal |author=Patel S, Patel S, Marwood R, ''et al.'' |title=Identification and pharmacological characterization of <nowiki>[125I]</nowiki>L-750,667, a novel radioligand for the dopamine D4 receptor |journal=Mol. Pharmacol. |volume=50 |issue=6 |pages=1658–64 |pmid=8967990 |url=http://molpharm.aspetjournals.org/cgi/pmidlookup?view=long&pmid=8967990|date=December 1996}}</ref>
* S 18126: 也叫 σ1 affin<ref name="pmid9765336">{{cite journal | author = Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL | title =<nowiki> S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride</nowiki> | journal = J. Pharmacol. Exp. Ther. | volume = 287 | issue = 1 | pages = 167–86 | date=1 October 1998| pmid = 9765336 | url = http://jpet.aspetjournals.org/cgi/content/abstract/287/1/167 | issn = }}</ref>
* [[Fananserin|Fananserin]] - 混合型5-HT<sub>2A</sub> / D<sub>4</sub> 拮抗剂
* [[Clozapine|Clozapine]]，一种典型的抗精神病药物

===反激动剂===

* FAUC F41: [[反激动剂|反激动剂]]，亚型选择性超过D<sub>2</sub>和 D<sub>3</sub>三个数量级<ref name="pmid18307287">{{cite journal | author = Prante O, Tietze R, Hocke C, Löber S, Hübner H, Kuwert T, Gmeiner P | title = Synthesis, Radiofluorination, and In Vitro Evaluation of Pyrazolo[1,5-a]pyridine-Based Dopamine D<sub>4</sub> Receptor Ligands: Discovery of an Inverse Agonist Radioligand for PET | journal = J. Med. Chem. | volume = 51| issue = 6| pages = 1800–10| year = 2008 | pmid = 18307287 | doi = 10.1021/jm701375u }}</ref><ref name="pmid11312915">{{cite journal | author = Lanig H, Utz W, Gmeiner P | title = Comparative molecular field analysis of dopamine D<sub>4</sub> receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine | journal = J. Med. Chem. | volume = 44 | issue = 8 | pages = 1151–7 | year = 2001 | pmid = 11312915 | doi = 10.1021/jm001055e }}</ref>

==可参见==
* [[精神病多巴胺假说|精神病多巴胺假说]]

==参考列表==
{{Reflist|2}}

==外部链接==
*{{cite web | url = http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2258 | title = Dopamine Receptors: D<sub>4</sub> | accessdate = | author = | authorlink = | coauthors = | date = | format = | work = IUPHAR Database of Receptors and Ion Channels | publisher = International Union of Basic and Clinical Pharmacology | pages = | language = | archiveurl = | archivedate = | quote = }}
* [https://web.archive.org/web/20110710193406/http://search.engrant.com/sp/DRD4/ Current Research on the DRD<sub>4</sub> Gene]
* {{MeshName|Receptors,+Dopamine+D4}}
* {{cite web | url = http://www.bio.davidson.edu/courses/genomics/2001/wilson/gene.html | title = Are you a thrill seeker?? | accessdate = 2008-04-05 | author = Marisa Wilson | authorlink = | coauthors = | date = | work = | publisher = Davidson College | pages = | language = | archiveurl = | archivedate = | quote = }}
* {{cite web|url=http://www.d4dr.net/d4dr_gene.htm |title=The D4DR Gene |accessdate=2008-04-05 |author= |authorlink= |coauthors= |date= |work= |publisher=D4DR Club |pages= |language= |archiveurl=https://web.archive.org/web/20080430134211/http://www.d4dr.net/d4dr_gene.htm |archivedate=2008-04-30 |quote= |deadurl=yes }}
{{NLM content}}
{{G protein-coupled receptors}}

{{DEFAULTSORT:Dopamine Receptor D4}}

[[Category:G蛋白偶联受体|Category:G蛋白偶联受体]]
[[Category:注意力不足過動症生物學|Category:注意力不足過動症生物學]]